跳至主要内容
临床试验/NCT03359122
NCT03359122已完成不适用

Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients-Retrospective Observational Cohort Study

AstraZeneca1 个研究点 分布在 1 个国家目标入组 10,067 人开始时间: 2018年6月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
10,067
试验地点
1
主要终点
Indicators of COPD control

研究概览

简要总结

The aim of this study is to examine the association of COPD maintenance inhalation medication (Inhaled Corticosteroid or ICS) adherence with COPD exacerbation healthcare resource utilization among COPD patients with exacerbation history.

详细描述

Objectives: The primary objective of this study is to examine the association of COPD maintenance inhalation medication (Inhaled Corticosteroid or ICS) adherence with COPD exacerbation healthcare resource utilization among COPD patients with exacerbation history.

Study design: This study is a retrospective database analysis using 2014-2016 Guangzhou City health insurance database.

Data Source(s): Guangzhou city health insurance database will be used for this study. All outpatient and inpatient visits for one patient during 2014-2016 were available.

Study Population: This study will include patients with a physician COPD diagnosis in Guangzhou city health insurance database during 2015 and with complete treatment data during 1 year before and 1 year after the index date. The rough sample size of the study population was 49,000.

Outcome(s):

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with COPD in 2015;
  • Patients had complete hospital visit data available during pre-index 1 year period and post 1 year follow-up;
  • Patients had at least one COPD exacerbation during 1 year prior to the index date;
  • Patients had at least 2 COPD maintenance medication claims during post index 1 year period, as 2 claims are recommended to calculate adherence.

排除标准

  • Inability to determine diagnoses from claims;
  • Individuals with other chronic respiratory conditions such as respiratory cancer, pulmonary fibrosis, asthma.

结局指标

主要结局

Indicators of COPD control

时间窗: 2015.01-2016.12

Number of exacerbations

Health resource utilization

时间窗: 2015.01-2016.12

Emergency department (ED) visit number

Costs of inpatient treatment

时间窗: 2015.01-2016.12

Cost of all-cause inpatient treatment

次要结局

未报告次要终点

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Association of COPD Maintenance Medication Adherence... | 临床试验